Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women

Cessation, Smoking Clinical Trial

— GESTABAC  

Official title:

Effectiveness of an Intervention in Primary Care to Promote Smoking Cessation in Pregnant Women: Cluster Randomized Controlled Trial.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01872156
• Other study ID #: SOMAMFYC11/2012
• Status: Completed
• Phase: N/A
• First received: April 24, 2013
• Last updated: August 11, 2017
• Start date: December 2013
• Est. completion date: July 2017

Study information

• Verified date: August 2017
• Source: Gerencia de Atención Primaria, Madrid
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of the behavior treatment accompanied by self-help materials in Primary health care, across the intervention of the midwifes in the pregnancy follow-up visits.

Description:

Aim: To evaluate the efficiency of an intervention in smoking based on a clinical practice guideline on the part of the primary care professionals on tobacco abstinence at the conclusion of the pregnancy self referred and validated with cooximetry.

Secondary objectives:

1. To evaluate the effectiveness of an intervention in smoking based on a clinical practice guideline on the part of the primary care professionals on the tobacco abstinence 6 months after the childbirth.

2. The effectiveness of the intervention values on the weight of the newborn child, the number of childbirths pre-term and the perinatal mortality.

3. To study the effectiveness of the intervention in smoking on the maintenance of the breast-feeding to 3 and 6 months.

Method:

Design: cluster randomized controlled trial. Setting: study in Health Centers Primary Care of Area of Madrid Health Service.

Sample size adjusted for design effect: number of smoking women in every branch would be of 350.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 350
• Est. completion date: July 2017
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older

• pregnant at 20 weeks or less of gestation

• attending her first prenatal visit with any of the participating prenatal care teams (this first prenatal visit takes place usually around 6-12 weeks of pregnancy)

• defining herself as a current cigarette smoker or recent ex-smoker (see below for a definition of these terms)

• being able to meet the requisites of the trial:

• being available for the next 15 months

• defining herself as fluent in reading and speaking Spanish to understand the study procedures and to comply with them

• meeting no exclusion criterion; and

• willing and able to give informed consent for participation in the study

Exclusion Criteria:

• communication barrier;

• active addictions to other psychoactive substances

• involved in any other formal smoking cessation program or in another trial during the study period; or

• does not consent to participate in the study

Related Conditions & MeSH terms

• Cessation, Smoking

Intervention

Other:
• Intervention GESTABAC
Intervention based on the "Clinician`s Guide to helping Pregnant Women Quit Smoking" on the rates of abstinence of the patients in whom it has been controlled in this period of time, at the end of the pregnancy and after the childbirth.
• Control Group
The group control will act according to usual management.

Locations

Country	Name	City	State
Spain	Gerencia de Atención Primaria	Madrid

Sponsors (1)

Lead Sponsor	Collaborator
Gerencia de Atención Primaria, Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of abstinence of tobacco	Rate of abstinence of tobacco to 20-28 weeks of childbearing , to 36-38 weeks and to 6 postpartum (post-childbearing) months. The abstinence will be validated for cooximetry.	6 months

External Links

•   An online platform to facilitate communication and dissemination of information between the research group